Patients like us have exhausted our other options, and we deserve a chance to see if ketamine therapy can help.

Our Mission

The Ketamine Advocacy Network’s mission is to spread awareness of ketamine therapy for treatment-resistant depression, bipolar, and PTSD, and to make this treatment available and affordable for all who need it.  We fulfill our mission by:

1. Promoting public awareness of ketamine therapy
We do this through media appearances, interviews, articles, speaking engagements, and direct outreach.
2. Arming sufferers with resources and practical knowledge about the treatment
We do this through assets made available on our website, and by fostering a community of patients to steadily build a collective body of knowledge.
3. Fighting for insurance coverage of the treatment
We do this by gathering data from patients and clinicians that will show insurance carriers they can gain financially by covering ketamine therapy, and by organizing grass-roots support to apply pressure to the carriers.
4. Supporting ketamine therapy providers
We do this by sharing our extensive patient experiences with providers, helping them keep current on published research, and by connecting practitioners with each other.

Our Vision

We envision ketamine therapy being widely offered and easily accessed by the patients who truly need it. We’ll stop advocating when all of the following transpires…

Ketamine therapy will become a universally-accepted treatment for extreme cases of depression, bipolar, and PTSD.  It will be FDA-approved for this purpose, and insurance will cover it.  Long-term treatment regimens will be developed.  Counseling therapies will be designed specifically to work in tandem with ketamine therapy, to help patients turn ketamine’s rapid effects into lasting benefits.  The ketamine revolution will help the public understand that many cases of depression/bipolar/PTSD are rooted not in emotional disturbances, but rather a physical injury to the brain caused by forces that include excessive exposure to glucocorticoid hormones produced by stress; chronic autoimmune-induced neuroinflammation; and others.

The research into ketamine’s mechanism of action will one day yield a treatment that is even more effective than ketamine.  If that treatment is universally available, covered by insurance, and not subject to massive opposition like ketamine, the Ketamine Advocacy Network will happily shut down.

Use the form below to critique this webpage, or send an email to feedback@ketaminenetwork.org.  Your comments are private.

Your Username

Your Name (required)

Your email (optional)

Your comments about this page